Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease

This study is currently recruiting participants.

Verified by National Taiwan University Hospital, May 2008

Sponsors and Collaborators:	National Taiwan University Hospital National Science Council, Taiwan
Information provided by:	National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00792896

Purpose

Family usually had a lot of burden to tell the truth to patients. The purpose of this study is to assess the effect of education materials and family conference for advanced cancer patients and family.

Condition	Intervention
Advanced Cancer Metastatic Cancer	Behavioral: family conference

MedlinePlus related topics: Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Health Services Research, Open Label, Parallel Assignment
Official Title:	A Longitudinal Study That Assessed the Effectiveness of Intervention Toward

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:

Questionnaires [ Time Frame: before and 1 week after the intervention ] [ Designated as safety issue: No ]

Estimated Enrollment:	150
Study Start Date:	May 2008
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Experimental Family conference + education materials	Behavioral: family conference family conference
2: No Intervention education materials

Eligibility

Ages Eligible for Study:	20 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

advanced or metastatic cancer patients
more than 20 years old
clear consciousness and be able to communicate

Exclusion Criteria:

refuse to know the statement of himself/herself disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00792896

Contacts

Contact: We-Yu Hu, Ph.D

23123456 ext 88428

weyuhu@ntu.edu.tw

Locations

Taiwan
National Taiwan University Hospital	Recruiting
Taipei, Taiwan, 100
Contact: We-Yu Hu, Ph.D 23123456 ext 88428 weyuhu@ntu.edu.tw
Principal Investigator: We-Yu Hu, Ph.D

Sponsors and Collaborators

National Taiwan University Hospital

National Science Council, Taiwan

More Information

Responsible Party:	Department of Nursing ( 1, Jen-Ai Road Section 1, Taipei, Taiwan )
Study ID Numbers:	200803051R
Study First Received:	November 16, 2008
Last Updated:	November 17, 2008
ClinicalTrials.gov Identifier:	NCT00792896
Health Authority:	Taiwan: Department of Health

Study placed in the following topic categories:

Neoplasm Metastasis

Additional relevant MeSH terms:

Neoplasms
Neoplastic Processes
Pathologic Processes

ClinicalTrials.gov processed this record on January 15, 2009